VSTM FY 2013 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$375M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$41M

Net Income

-$41M

EPS (Diluted)

$-21.80

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$125M

Total Liabilities

$8M

Stockholders' Equity

$117M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$41M	-$32M	-28.5%
Net Income	-$41M	-$32M	-28.8%